Abstract
Calcific aortic valve stenosis is the most frequent valve disease and the most common cause of aortic valve replacement in the western world, concomitant with aging of the general population and habitual consumption of a high-calorie diet. For years it was considered to be a passive wear and tear process but now it is recognized as an active process similar to atherosclerosis with involvement of several mediators, such as adhesion molecules, TGFs, cathepsin enzymes and bone regulatory proteins. As conviction grew that aortic stenosis has a genesis similar to atherosclerosis, the hypothesis that statins might be able to alter the progression of the disease also grew. Various retrospective studies confirmed the benefits of statin use at an earlier stage of the disease, but some disappointing results were demonstrated by randomized clinical trials.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
